Management of ischemic heart disease in patients with chronic kidney disease.
Patients with chronic kidney disease (CKD) and ischemic heart disease (IHD) have strikingly high mortality rates. In the general population, there has been a reduction in the mortality and morbidity rates for IHD through the implementation of effective risk-factor-reduction programs and better interventions for patients with established IHD. No such trend has been observed in patients with end-stage kidney disease. This review article addresses the following topics: (i) epidemiology, pathogenesis, clinical CKD patients with IHD; (ii) diagnostic modalities for IHD and their limitation in CKD patients; (iii) medical treatment options and revascularization strategies for these high-risk patients; and (iv) optimal cardiovascular risk management. Generally, in CKD patients with IHD an aggressive approach to IHD is warranted, a low threshold for diagnostic testing should be employed, and awaiting a clinical trial targeting these patients they should be considered for all proven strategies to improve outcomes.
Mutwali
Arif
A
Department of Medicine, Division of Nephrology, National University of Ireland, Galway, Ireland.
Glynn
Liam G
LG
Reddan
Donal
D
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D017023:Coronary Angiography / Q000379:methods; D004562:Electrocardiography; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D012307:Risk Factors